Beijing ServiPharm GPS Co., Ltd., as the subsidiary of Beijing Holley-Cotec Pharmaceuticals Co., Ltd., is committed to provide professional technical support and consulting services to help China’s pharmaceutical enterprises enter the international market, drive and accelerate international transformation of China’s pharmaceutical industry and self-owned brands in the aspects of international registration, clinical trails, GMP, etc., and help enterprises break technical barriers and barriers of drug policies and regulations and quickly enter the African market or pass the PQ certification of WHO. At present, the company has more than 10 professional senior technical staff members.
Main services include:

(1) Guide the entry into the African market

On the basis of the overall level, technological status and talent pool of China’s pharmaceutical industry, the strategy of gradually entering the Europe and the United States-based international markets with Africa as a springboard is increasingly accepted by many China’s pharmaceutical enterprises. Therefore, the company provides the following value-added services to the pharmaceutical enterprises planning to enter the local public and private markets in African and Southeast Asian countries:
● Formulate marking plan according to the situation of the enterprise;
● Recommend agents and suggest sales channel development and management;
● Design package insert according to the drug policy of the country to be registered;
● Prepare registration materials and assist the local drug administration bureau to conduct factory inspection.
Currently, our service channels can cover the following African countries: Kenya, Uganda, Tanzania, Malawi, Zambia, Somalia, Nigeria, Ghana, Comoros, Mauritania, Congo-Brazzaville, Senegal, Côte d'Ivoire, Gabon, Togo, Guinea, Burkina Faso, Cameroon, Benin, Zanzibar Island, Mali, Congo-Kinshasa, Ethiopia, South Africa, Mozambique, etc.; and our network can cover the following Southeast Asian countries: Pakistan, Cambodia, Myanmar, Indonesia, etc.
So far, the company has successfully introduced more than ten kinds of pharmaceutical preparations into the international market and the government public procurement system.

 

(2) Guide PQ certification of the WHO

  

Currently, the PQ certification of the WHO, with the standards and requirements lower than those of EU FDA and the U.S. FDA, has become the shortcut for domestic medicines entering the international market, the best way for China’s pharmaceutical enterprises to conduct internationalization transition and early accumulation of experience and money, and the springboard for China’s pharmaceutical enterprises to enter the international market. Meanwhile, with the start of the AMF policy, China’s pharmaceutical enterprises are further required to accelerate the application for the PQ certification so as to obtain the permit for entering the international public markets. Our company will provide the following services for the enterprises that are willing to pass the PQ certification in the aspects of the application procedures and difficulties of the PQ certification: